Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gold

Showing results (1001-1010 of 1,272) with videos related to

Pageof 128
Sort By:
Schizophrenia Bulletin|January 3, 2025
Revisiting the Defeatist Performance Belief Scale in Adults With Schizophrenia and Youth at Clinical High-Risk for Psychosis: A Comprehensive Psychometric AnalysisLauren Luther, Anthony O Ahmed, Paul M Grant, et al.
Schizophrenia Research|December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophreniaDaniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
Molecular Psychiatry|February 14, 2026
Computational phenotypes underlying effort-based decision-making and negative symptoms in a transdiagnostic severe mental illness sampleLauren Luther, Jessica A Cooper, Michael T Treadway, et al.
Schizophrenia Research|January 16, 2026
Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophreniaDeanna L Kelly, Christopher M Lee, Gopal Vyas, et al.
Schizophrenia (Heidelberg, Germany)|May 12, 2025
Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlatesTanya Tran, Brian P Keane, Judy L Thompson, et al.
Schizophrenia Bulletin|June 19, 2018
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in SchizophreniaAnthony O Ahmed, Brian Kirkpatrick, Silvana Galderisi, et al.
Journal of Clinical Psychopharmacology|June 18, 2015
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent SymptomsDeanna L Kelly, Kelli M Sullivan, Joseph P McEvoy, et al.
Journal of Psychiatry & Neuroscience : JPN|April 3, 2019
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility studyDeanna L. Kelly, Haley K. Demyanovich, Katrina M. Rodriguez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2006
Baseline neurocognitive deficits in the CATIE schizophrenia trialRichard S E Keefe, Robert M Bilder, Philip D Harvey, et al.
The American Journal of Psychiatry|January 4, 2008
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validityKeith H Nuechterlein, Michael F Green, Robert S Kern, et al.
Pageof 128

Showing results (1001-1010 of 1,272) with videos related to

Sort By:
Pageof 128
Schizophrenia Bulletin|January 3, 2025
Revisiting the Defeatist Performance Belief Scale in Adults With Schizophrenia and Youth at Clinical High-Risk for Psychosis: A Comprehensive Psychometric AnalysisLauren Luther, Anthony O Ahmed, Paul M Grant, et al.
Schizophrenia Research|December 16, 2011
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophreniaDaniel C Javitt, Robert W Buchanan, Richard S E Keefe, et al.
Molecular Psychiatry|February 14, 2026
Computational phenotypes underlying effort-based decision-making and negative symptoms in a transdiagnostic severe mental illness sampleLauren Luther, Jessica A Cooper, Michael T Treadway, et al.
Schizophrenia Research|January 16, 2026
Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophreniaDeanna L Kelly, Christopher M Lee, Gopal Vyas, et al.
Schizophrenia (Heidelberg, Germany)|May 12, 2025
Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlatesTanya Tran, Brian P Keane, Judy L Thompson, et al.
Schizophrenia Bulletin|June 19, 2018
Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in SchizophreniaAnthony O Ahmed, Brian Kirkpatrick, Silvana Galderisi, et al.
Journal of Clinical Psychopharmacology|June 18, 2015
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent SymptomsDeanna L Kelly, Kelli M Sullivan, Joseph P McEvoy, et al.
Journal of Psychiatry & Neuroscience : JPN|April 3, 2019
Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility studyDeanna L. Kelly, Haley K. Demyanovich, Katrina M. Rodriguez, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 28, 2006
Baseline neurocognitive deficits in the CATIE schizophrenia trialRichard S E Keefe, Robert M Bilder, Philip D Harvey, et al.
The American Journal of Psychiatry|January 4, 2008
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validityKeith H Nuechterlein, Michael F Green, Robert S Kern, et al.
Pageof 128